RecruitingNCT00616317
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Sponsor
University of California, Davis
Enrollment
50 participants
Start Date
Sep 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Eligibility
Min Age: 1 MinuteMax Age: 18 Years
Inclusion Criteria4
- years of age or younger at the onset of disease
- Presence of Vascular Thrombosis
- UC Davis patient
- Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
Exclusion Criteria2
- Infants born to mothers with APS
- Infants with congenital thrombophilia
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00616317
Related Trials
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
NCT0019806810 locations
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT070879122 locations
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT072367621 location
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
NCT072368012 locations
Rheumatology Patient Registry and Biorepository
NCT044020861 location